These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35972839)

  • 1. Synthesis, anticholinesterase activity, molecular docking, and molecular dynamic simulation studies of 1,3,4-oxadiazole derivatives.
    Durmaz Ş; Evren AE; Sağlık BN; Yurttaş L; Tay NF
    Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200294. PubMed ID: 35972839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in Vitro Cholinesterase Inhibition, Molecular Docking, DFT, and ADME Studies of Novel 1,3,4-Oxadiazole-2-Thiol Derivatives.
    Tariq S; Mutahir S; Khan MA; Mutahir Z; Hussain S; Ashraf M; Bao X; Zhou B; Stark CBW; Khan IU
    Chem Biodivers; 2022 Aug; 19(8):e202200157. PubMed ID: 35767725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of phenoxy methyl-oxadiazole compounds against Alzheimer's disease.
    Evren AE; Nuha D; Özkan BNS; Kahraman Ç; Gönülalan EM; Yurttaş L
    Arch Pharm (Weinheim); 2024 Aug; 357(8):e2400115. PubMed ID: 38657203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO-B dual inhibitors.
    Osmaniye D; Evren AE; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100450. PubMed ID: 34931332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
    Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
    Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors.
    Taha M; Rahim F; Uddin N; Khan IU; Iqbal N; Anouar EH; Salahuddin M; Farooq RK; Gollapalli M; Khan KM; Zafar A
    Int J Biol Macromol; 2021 Oct; 188():1025-1036. PubMed ID: 34390751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
    Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
    Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and molecular docking simulation of new benzimidazole-thiazole hybrids as cholinesterase inhibitors.
    Dawood DH; Srour AM; Omar MA; Farghaly TA; El-Shiekh RA
    Arch Pharm (Weinheim); 2024 Jan; 357(1):e2300201. PubMed ID: 37937360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of New 1,3,4-Oxadiazoles with Dual Activity Targeting the Cholinergic Pathway as Effective Anti-Alzheimer Agents.
    Elghazawy NH; Zaafar D; Hassan RR; Mahmoud MY; Bedda L; Bakr AF; Arafa RK
    ACS Chem Neurosci; 2022 Apr; 13(8):1187-1205. PubMed ID: 35377601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biochemical and computational evaluations of novel bis-acylhydrazones of 2,2'-(1,1'-biphenyl)-4,4'-diylbis(oxy))di(acetohydrazide) as dual cholinesterase inhibitors.
    Ibrahim M; Halim SA; Latif A; Ahmad M; Ali S; Ullah S; Khalid A; Abdalla AN; Khan A; Al-Harrasi A; Ali M
    Bioorg Chem; 2024 Mar; 144():107144. PubMed ID: 38281382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of novel xanthene-based thiazoles as potential antidiabetic agents.
    Naseem S; Shafiq Z; Taslimi P; Hussain S; Taskin-Tok T; Kisa D; Saeed A; Temirak A; Tahir MN; Rauf K; El-Gokha A
    Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200356. PubMed ID: 36220614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
    Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
    Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anticholinesterase activity of new substituted benzo[d]oxazole-based derivatives.
    Pouramiri B; Moghimi S; Mahdavi M; Nadri H; Moradi A; Tavakolinejad-Kermani E; Firoozpour L; Asadipour A; Foroumadi A
    Chem Biol Drug Des; 2017 May; 89(5):783-789. PubMed ID: 27863021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Molecular Docking of New Bis-Thiazolidinone-Based Chalcone Analogs as Effective Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Hussain R; Rahim F; Rehman W; Taha M; Khan S; Zaman K; Adnan Ali Shah S; Wadood A; Imran S; Abdellatif MH
    Chem Biodivers; 2022 Oct; 19(10):e202200323. PubMed ID: 35997224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of 7-diethylaminocoumarin-based 1,3,4-oxadiazole derivatives with anti-acetylcholinesterase activities.
    Yu X; Zhao YF; Huang GJ; Chen YF
    J Asian Nat Prod Res; 2021 Sep; 23(9):866-876. PubMed ID: 32815409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive sulfonyl hydrazones with alkyl derivative: Characterization, ADME properties, molecular docking studies and investigation of inhibition on choline esterase enzymes for the diagnosis of Alzheimer's disease.
    Bilen E; Özdemir Özmen Ü; Çete S; Alyar S; Yaşar A
    Chem Biol Interact; 2022 Jun; 360():109956. PubMed ID: 35452634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
    Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
    Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
    Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
    Vitorović-Todorović MD; Koukoulitsa C; Juranić IO; Mandić LM; Drakulić BJ
    Eur J Med Chem; 2014 Jun; 81():158-75. PubMed ID: 24836068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.